Edesa Biotech Inc. (EDSA)
NASDAQ · Healthcare
Edesa Biotech Inc. Revenue 2012–2021
Edesa Biotech Inc. annual/quarterly revenue history and growth rate from 2012 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Edesa Biotech Inc. revenue for the quarter ending June 30, 2021 was 0, a 100.00% decrease year-over-year.
- Edesa Biotech Inc. revenue for the twelve months ending June 30, 2021 was 109985, a 49.74% decrease year-over-year.
- Edesa Biotech Inc. annual revenue for 2021 was 0, a 100.00% decrease from 2020.
- Edesa Biotech Inc. annual revenue for 2020 was 328801.
- Edesa Biotech Inc. annual revenue for 2018 was 0, a 100.00% decrease from 2018.
- Edesa Biotech Inc. annual revenue for 2018 was 211849.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Edesa Biotech Inc. (EDSA) — Frequently Asked Questions
Edesa Biotech Inc. (EDSA) is a publicly traded US company. It has a market capitalization of $69M. Explore EDSA's stock price, financial statements, earnings history, margins and key ratios below.
What is Edesa Biotech Inc.'s market cap?
Edesa Biotech Inc. (EDSA) has a market capitalization of $69M.
What is the EDSA stock price?
EDSA trades at $5.21 (+5.47% on the day).
Is EDSA profitable?
In fiscal 2021, Edesa Biotech Inc. reported net income of -$13M.